🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Reliability of PHAS in Postural Hyperkyphosis

Recruitingn/aAges 8 Years - 65 YearsAllIstanbul University - Cerrahpasa
NCT06907901 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This observational, cross-sectional study aims to evaluate the reliability of the Postural Habits and Awareness Scale (PHAS) in patients with postural hyperkyphosis. The PHAS is designed to assess individuals' postural awareness and habits through four subscales. A total of 128 participants diagnosed with postural hyperkyphosis will complete the PHAS and the Kyphosis-Specific Spinal Appearance Questionnaire (KSSA). Test-retest reliability will be assessed by reapplying the PHAS after two weeks. Internal consistency, test-retest reliability, and concurrent validity will be analyzed. The study aims to provide a valid and reliable tool for evaluating postural awareness in clinical practice and future rehabilitation studies.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age between 8 and 65 years * Diagnosed with postural hyperkyphosis (Cobb angle ≥ 50° confirmed by clinical and radiological evaluation) * Ability to perform daily activities independently * Voluntary participation and signed informed consent Exclusion Criteria: * Presence of scoliosis or other spinal deformities * Kyphosis due to severe osteoporosis or pathological fractures * Diagnosis of ankylosing spondylitis or other inflammatory spinal diseases * Functional limitations due to acute or chronic pain * Previous postural awareness training or spinal rehabilitation within the last 6 months * Cognitive impairment or severe psychiatric disorder preventing independent questionnaire completion
💊

What it tests

  • PHAS Assessment
📍

Where

1 site
Istanbul University-Cerrahpasa
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy